Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Urovant Sciences Ltd (UROV)

Urovant Sciences Ltd (UROV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 531,746
  • Shares Outstanding, K 32,743
  • Annual Sales, $ 0 K
  • Annual Income, $ -146,750 K
  • 60-Month Beta 2.35
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade UROV with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -5.14
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/11/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -2.27
  • Number of Estimates 2
  • High Estimate -1.93
  • Low Estimate -2.61
  • Prior Year -1.57
  • Growth Rate Est. (year over year) -44.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.10 +0.84%
on 03/02/21
16.26 -0.12%
on 03/19/21
+0.07 (+0.43%)
since 02/26/21
3-Month
16.03 +1.31%
on 12/30/20
16.26 -0.12%
on 03/19/21
+0.20 (+1.25%)
since 12/24/20
52-Week
7.15 +127.13%
on 11/02/20
16.26 -0.12%
on 03/19/21
+6.09 (+60.00%)
since 03/26/20

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing therapies for urologic conditions. The company's product candidate pipeline consists of vibegron, an oral, once-daily, small molecule beta-3 agonist being evaluated in an international...

See More

Key Turning Points

3rd Resistance Point 16.28
2nd Resistance Point 16.26
1st Resistance Point 16.25
Last Price 16.24
1st Support Level 16.22
2nd Support Level 16.20
3rd Support Level 16.19

See More

52-Week High 16.26
Last Price 16.24
Fibonacci 61.8% 12.78
Fibonacci 50% 11.70
Fibonacci 38.2% 10.63
52-Week Low 7.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar